Skip to main content
Gastroenterology Research and Practice logoLink to Gastroenterology Research and Practice
. 2021 May 18;2021:9823426. doi: 10.1155/2021/9823426

Corrigendum to “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori

Lingyun Zhang 1, Yu Lan 1,, Qi Wang 1, Yuexia Zhang 1, Xiaobei Si 1
PMCID: PMC8169254  PMID: 34122540

In the article titled “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori” [1], there was an error in Subjects and Methods. This error is shown below:

“(Wyeth-Palace Pharmaceutical Co., Ltd, 1.0g, BID)” should read “(Wyeth-Palace Pharmaceutical Co., Ltd, 0.1 g, BID).”

References

  • 1.Zhang L., Yu L., Wang Q., Zhang Y., Si X. Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori. Gastroenterology Research and Practice. 2019;2019:6. doi: 10.1155/2019/9251879.9251879 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gastroenterology Research and Practice are provided here courtesy of Wiley

RESOURCES